We are pleased to announce an expansion of the services offered by the StemCell Facility starting this year, aimed at supporting users at different levels of experience with induced pluripotent stem cells (iPSCs).

For users who are not familiar with routine iPSC handling, the facility can receive commercially ordered iPSC lines on your behalf. We offer thawing, expansion, and cryopreservation of the required number of vials to support your downstream experiments. In addition, we can maintain iPSC lines in culture and provide cells to users at the time they are needed, ensuring consistent quality and reducing the technical burden on individual laboratories.

As part of our quality control services, we continue to offer testing of iPSC pluripotency through the embryoid body differentiation assay, assessing the ability of cells to differentiate into the three germ layers: ectoderm, mesoderm, and endoderm.

For users interested in iPSC-derived models, the facility provides differentiation of iPSCs into medium spiny neurons as well as striatal organoids. These services are designed to support research focused on neuronal development and disease modeling.

In addition, we are currently establishing a protocol for the differentiation of iPSCs into cortical neurons. This service is expected to become available in the second half of the year.

We warmly welcome new users to the StemCell Facility and are always open to suggestions, feedback, and discussions about additional services that could support your research needs.